Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current pharmaceutical design

• Publication date

  2015-08-31

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.2174/1381612821666150910113031PMID 26354926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension.

  2015cited by this paper
• Glycyrrhizin Conjugated Dendrimer and Multi-Walled Carbon Nanotubes for Liver Specific Delivery of Doxorubicin.

  2015cited by this paper
• VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes.

  2015cited by this paper
• Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics

  2015cited by this paper
• Generation Dependent Safety and Efficacy of Folic Acid Conjugated Dendrimer Based Anticancer Drug Formulations

  2015cited by this paper
• Development of omega-3 phospholipid-based solid dispersion of fenofibrate for the enhancement of oral bioavailability.

  2015cited by this paper
• G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.

  2015cited by this paper
• Matrix tablets for sustained release of repaglinide: Preparation, pharmacokinetics and hypoglycemic activity in beagle dogs.

  2015cited by this paper
• Au-Nanomaterials as a Superior Choice for Near-Infrared Photothermal Therapy

  2014cited by this paper
• Nanotechnology-based intelligent drug design for cancer metastasis treatment.

  2014cited by this paper
• Aging and cardiovascular diseases: the role of gene-diet interactions.

  2014cited by this paper
• Sustained release of milrinone delivered via microparticles in a rodent model of myocardial infarction.

  2014cited by this paper
• Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature.

  2014cited by this paper
• Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

  2014cited by this paper
• Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.

  2014cited by this paper
• Cardiovascular risk and psoriasis: beyond the traditional risk factors.

  2014cited by this paper
• Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector.

  2014cited by this paper
• Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.

  2014cited by this paper
• Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.

  2014cited by this paper
• Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis.

  2014cited by this paper
• Dendrimer, Liposomes, Carbon Nanotubes and PLGA Nanoparticles: One Platform Assessment of Drug Delivery Potential

  2014cited by this paper
• Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100.

  2014cited by this paper
• Comparison of a solid SMEDDS and solid dispersion for enhanced stability and bioavailability of clopidogrel napadisilate.

  2014cited by this paper
• Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.

  2014cited by this paper
• Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension.

  2014cited by this paper
• Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.

  2014cited by this paper
• Chemistry of conjugation to gold nanoparticles affects G-protein activity differently

  2013cited by this paper
• Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors.

  2013cited by this paper
• Characterization of semi-solid Self-Emulsifying Drug Delivery Systems (SEDDS) of atorvastatin calcium by Raman image spectroscopy and chemometrics.

  2013cited by this paper
• The Potential Efficacy of R8-Modified Paclitaxel-Loaded Liposomes on Pulmonary Arterial Hypertension

  2013cited by this paper
• Cancer targeting potential of folate targeted nanocarrier under comparative influence of tretinoin and dexamethasone.

  2013cited by this paper
• Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability

  2013cited by this paper
• Formulation Development and Evaluation of Hybrid Nanocarrier for Cancer Therapy: Taguchi Orthogonal Array Based Design

  2013cited by this paper
• Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction.

  2013cited by this paper
• STAT6 siRNA Matrix-Loaded Gelatin Nanocarriers: Formulation, Characterization, and Ex Vivo Proof of Concept Using Adenocarcinoma Cells

  2013cited by this paper
• Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment.

  2012cited by this paper
• The golden age: gold nanoparticles for biomedicine.

  2012cited by this paper
• Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats.

  2012cited by this paper
• Haemocompatibility improvement of metallic surfaces by covalent immobilization of heparin-liposomes.

  2012cited by this paper
• Syntheses and characterization of lisinopril-coated gold nanoparticles as highly stable targeted CT contrast agents in cardiovascular diseases.

  2012cited by this paper
• The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B.

  2012cited by this paper
• Dendrimer-entrapped gold nanoparticles as potential CT contrast agents for blood pool imaging

  2012cited by this paper
• Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

  2012cited by this paper
• Carbon nanotubes promote growth and spontaneous electrical activity in cultured cardiac myocytes.

  2012cited by this paper
• Pulmonary toxicity of carbon nanotubes: a systematic report.

  2011cited by this paper
• Evaluation of dendrimer safety and efficacy through cell line studies.

  2011cited by this paper
• Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies.

  2011cited by this paper
• Nanomedicine approaches in vascular disease: a review.

  2011cited by this paper
• Highly hydroxylated fullerene localizes at the cytoskeleton and inhibits oxidative stress in adipocytes and a subcutaneous adipose-tissue equivalent.

  2011cited by this paper
• Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications.

  2011cited by this paper
• Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis

  2011cited by this paper
• Single-walled carbon nanotubes as optical materials for biosensing.

  2011cited by this paper
• Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment.

  2011cited by this paper
• Should Global Burden of Disease Estimates Include Depression as a Risk Factor for Coronary Heart Disease?

  2011cited by this paper
• Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison.

  2011cited by this paper
• Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.

  2010cited by this paper
• Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields

  2010cited by this paper
• Nanotechnology for synthetic high-density lipoproteins.

  2010cited by this paper
• Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

  2010cited by this paper
• Molecular Imaging of Atherosclerotic Plaques Targeted to Oxidized LDL Receptor LOX-1 by SPECT/CT and Magnetic Resonance

  2010cited by this paper
• Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release.

  2010cited by this paper
• Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation.

  2010cited by this paper
• Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation.

  2010cited by this paper
• Micro- and nanocarrier-mediated lung targeting

  2010cited by this paper
• Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)

  2010cited by this paper
• Gold nanoparticles for biology and medicine.

  2010cited by this paper
• Protein–nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia

  2010cited by this paper
• MR angiogenesis imaging with Robo4‐ vs. αVβ3‐targeted nanoparticles in a B16/F10 mouse melanoma model

  2010cited by this paper
• Local arterial nanoparticle delivery of siRNA for NOX2 knockdown to prevent restenosis in an atherosclerotic rat model

  2010cited by this paper
• Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.

  2010cited by this paper
• Red blood cell-mimicking synthetic biomaterial particles

  2009cited by this paper
• Intravenous Hemostat: Nanotechnology to Halt Bleeding

  2009cited by this paper
• A novel interdigitated capacitor based biosensor for detection of cardiovascular risk marker.

  2009cited by this paper
• Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis

  2009cited by this paper
• Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.

  2009cited by this paper
• Targeting redox signaling in the vascular wall: from basic science to clinical practice.

  2009cited by this paper
• Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam.

  2009cited by this paper
• Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics

  2009cited by this paper
• Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.

  2009cited by this paper
• Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis

  2009cited by this paper
• Potential in vitro effects of carbon nanotubes on human aortic endothelial cells.

  2009cited by this paper
• Multimodal nanoagents for the detection of intravascular thrombi.

  2009cited by this paper
• 18F labeled nanoparticles for in vivo PET-CT imaging.

  2009cited by this paper
• Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.

  2009cited by this paper
• Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats.

  2009cited by this paper
• Inflammation Imaging in Atherosclerosis

  2009cited by this paper
• PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist.

  2009cited by this paper
• Glyceryl Monooleate/Poloxamer 407 Cubic Nanoparticles as Oral Drug Delivery Systems: I. In Vitro Evaluation and Enhanced Oral Bioavailability of the Poorly Water-Soluble Drug Simvastatin

  2009cited by this paper
• Targeting atherosclerosis by using modular, multifunctional micelles

  2009cited by this paper
• Dendrimers as therapeutic agents: a systematic review.

  2009cited by this paper
• Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes.

  2009cited by this paper
• Templated spherical high density lipoprotein nanoparticles.

  2009cited by this paper
• Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy

  2008cited by this paper
• Three‐dimensional MR mapping of angiogenesis with α5β1(αvβ3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model

  2008cited by this paper
• Managing cardiovascular risk: the need for change

  2008cited by this paper
• Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies

  2008cited by this paper
• Dendrimers in oncology: an expanding horizon.

  2008cited by this paper
• Drug delivery with carbon nanotubes for in vivo cancer treatment.

  2008cited by this paper
• Fibrin Targeting of Echogenic Liposomes with Inactivated Tissue Plasminogen Activator

  2008cited by this paper
• Size-dependent denaturing kinetics of bovine serum albumin adsorbed onto gold nanospheres

  2008cited by this paper

• Nanotechnology-enabled delivery of phytoconstituents: Recent developments, applications, and regulatory considerations

  2025cites this paper
• Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives

  2025cites this paper
• Nanotechnology Innovations in Myocardial Infarction: Diagnosis, Treatment and the Way Forward

  2025cites this paper
• Journey into Tomorrow: Cardiovascular Wellbeing Transformed by Nano-Scale Innovations.

  2024cites this paper
• Nano Revolution in Cardiovascular Health: Nanoparticles (NPs) as Tiny Titans for Diagnosis and Therapeutics.

  2024cites this paper
• The recent applications of nanotechnology in the diagnosis and treatment of common cardiovascular diseases.

  2023cites this paper
• Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.

  2023cites this paper
• Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics

  2023cites this paper
• Scalable Design and Development of Modified Release Hydrochlorothiazide Formulation Employing Quality by Design Approach

  2022cites this paper
• Nanomaterials based flexible devices for monitoring and treatment of cardiovascular diseases (CVDs)

  2022cites this paper
• Evaluation of the Compatibility of Moxifloxacin with Selected Excipients Used in the Formulation of Nanopharmaceuticals

  2022cites this paper
• Nanodiagnosis and Nanotreatment of Cardiovascular Diseases: An Overview

  2021cites this paper
• Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug 'Etoposide'.

  2020cites this paper
• Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics

  2020cites this paper
• Fundamentals of diffusion and dissolution: dissolution testing of pharmaceuticals

  2020cites this paper
• Green graphene nanoplates for combined photo-chemo-thermal therapy of triple-negative breast cancer.

  2020cites this paper
• Employment of Quality by Design approach via Response Surface Methodology to Optimize and Develop Modified Release formulation of Hydrochlorothiazide.

  2020cites this paper
• Pharmacogenomics and pharmacoepigenomics: Impact on therapeutic strategies

  2020cites this paper
• Nanotechnology-Based Biopolymeric Oral Delivery Platforms for Advanced Cancer Treatment

  2020cites this paper
• CD44 receptor targeted ‘smart’ multi-walled carbon nanotubes for synergistic therapy of triple-negative breast cancer

  2020cites this paper
• Biomaterials for Sustained and Controlled Delivery of Small Drug Molecules

  2019cites this paper
• Cutaneous and Transdermal Drug Delivery

  2019cites this paper
• Transportation and Biointeraction Properties in Nanomaterials Across Biological Systems

  2019cites this paper
• Current Developments in Excipient Science

  2019cites this paper
• Use of Polymers in Controlled Release of Active Agents

  2019cites this paper
• Bionanotechnology in Pharmaceutical Research

  2019cites this paper
• Copolymers and Block Copolymers in Drug Delivery and Therapy

  2019cites this paper
• Fundamentals of Polymers Science Applied in Pharmaceutical Product Development

  2019cites this paper
• Health effects of pharmaceuticals and personal care products

  2019cites this paper
• Clinical Aspects and Regulatory Requirements for Nanomedicines

  2019cites this paper
• Surface Modification of Biomedically Essential Nanoparticles Employing Polymer Coating.

  2019cites this paper
• Fabrication of Mucoadhesive-Dendrimers as Solid Dosage Forms.

  2019cites this paper
• Novel Therapeutic Approaches for the Treatment of Leishmaniasis

  2019cites this paper
• Functionalized Carbon Nanotubes for Protein, Peptide, and Gene Delivery

  2019cites this paper
• Nanotechnology in Tissue Engineering

  2019cites this paper
• Hyaluronic Acid as an Emerging Technology Platform for Silencing RNA Delivery

  2019cites this paper
• Guiding Factors and Surface Modification Strategies for Biomaterials in Pharmaceutical Product Development

  2019cites this paper
• Gold Nanoparticles to Tackle Drug Resistance in Cancer

  2019cites this paper
• Gold nanoparticles for nanotheranostics in leukemia – Addressing Chronic Myeloid Leukemia

  2018cites this paper
• Toxicity of nanostructured biomaterials

  2018cites this paper
• Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer

  2018cites this paper
• Dissolution Profile Consideration in Pharmaceutical Product Development

  2018cites this paper
• Graphene: A versatile platform for nanotheranostics and tissue engineering

  2018cites this paper
• Peptide and Protein-Based Therapeutic Agents

  2017cites this paper
• Application of Gold Nanorods in Cardiovascular Science

  2017cites this paper
• The Potential Roles of Radionanomedicine and Radioexosomics in Prostate Cancer Research and Treatment.

  2017cites this paper
• Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.

  2017cites this paper
• Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions

  2017cites this paper
• The use of nanoscaffolds and dendrimers in tissue engineering.

  2017cites this paper
• Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.

  2017cites this paper
• Recent Advances in Oncological Submissions of Dendrimer.

  2017cites this paper
• Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route.

  2017cites this paper
• Carbon Nanotubes in Targeting and Delivery of Drugs

  2017cites this paper
• Solid Lipid Nanoparticles for Targeting and Delivery of Drugs and Genes

  2017cites this paper
• Molecular dynamics simulation strategies for designing carbon-nanotube-based targeted drug delivery.

  2017cites this paper
• Nanotechnology for the Development of Nanomedicine

  2017cites this paper
• RNAi-combined nano-chemotherapeutics to tackle resistant tumors.

  2016cites this paper
• Novel Therapeutic Strategies for Cardiovascular Disease Treatment: From Molecular Level to Nanotechnology.

  2015cites this paper
• Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?

  2015cites this paper
• Yemen Journal of Medicine

  year unknowncites this paper